Sadly, our dear colleague Andy Spencer passed away peacefully on 13th October, 2017.
Andy retired from a 40+-year-long career in toxicological pathology in March 2016. After graduating from Glasgow Veterinary School, and being granted a PhD in 1978, Andy worked at Inveresk Research in Scotland and at Pfizer in France, before settling in Alnwick (Northumberland, England). He spent more than 30 years of his working life at this research site, which was successively owned by Sterling Winthrop, Sanofi, Sanofi-Synthelabo, Sanofi-Aventis and Covance. He was a highly valued and respected colleague, working for many years as the Head of Pathology and Named Veterinary Surgeon in Preclinical Drug Safety Assessment. He contributed to the successful development of many important drugs, like oxaliplatin for the treatment of colorectal cancer, and statins for cardiovascular disease.
Andy has been an active BSTP member since its inception, serving as its Honorary Treasurer for 12 years. He was also examiner for the Royal College of Pathologists in laboratory animal pathology for 20 years and published more than 30 peer reviewed scientific articles, including the recent INHAND manuscript on the histopathology of the gastrointestinal tract, salivary glands and pancreas in rodents. His last Society contribution was through the lectures given at the 2017 Symposium on the Digestive system, where he presented lesions and terminology described in this INHAND publication.
Andy will be remembered for his kindness, patience, work ethics, enthusiasm and his hobbies. Andy fought his inexorable diagnosis of glioblastoma multiforme bravely till the end and will be sorely missed.
Our thoughts are with Andy's wife Joyce, their children Peter, Callum, Donald and Claire, and his family, friends and colleagues.